The U.S. Patent and Trademark Office has allowed a patent titled, “Method for Inducing an Immune Response and Formulations Thereof” for CEL-SCI Corporation’s LEAPS technology. The patented invention relates to methods for diagnosing, preventing, and treating disease by generating or modulating the immune response through the use of specific peptides. This specific allowed patent expands the…